Basics Lyell Immunopharma, Inc. IPO Date: June 17, 2021 Sector: Healthcare Industry: Biotech Market Cap: $233.42M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.20% Avg Daily Range (30 D): $0.40 | 3.54% Avg Daily Range (90 D): $0.43 | 4.81% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .2M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 59 Avg Trade Size (Sh.) (90 D): 126 Institutional Trades Total Inst.Trades: 340 Avg Inst. Trade: $1.98M Avg Inst. Trade (30 D): $2.79M Avg Inst. Trade (90 D): $2.79M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.31M Avg Closing Trade (30 D): $6.72M Avg Closing Trade (90 D): $6.72M Avg Closing Volume: 28.01K     News Jul 29, 2025 @ 7:46 PM Biotech Underdogs Line Up for Pivotal Shots at Gam... Source: Prnewswire Jun 23, 2025 @ 9:00 PM Lyell Immunopharma to Participate in the H.C. Wain... Source: N/A May 1, 2025 @ 1:00 PM Lyell Immunopharma Announces Oral Presentation of ... Source: Lyell Immunopharma, Inc. Oct 24, 2024 @ 8:00 PM Lyell Immunopharma to Acquire ImmPACT Bio and Prio... Source: Globe Newswire Oct 4, 2024 @ 1:00 PM Lyell Immunopharma Announces the Acceptance Abstra... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-7.31 $-2.89 $-.18 Diluted EPS $-7.31 $-2.89 $-.18 Revenue $ .06M $ .01M $ .01M Gross Profit $ $ $ Net Income / Loss $ -331.4M $ -42.68M $ -52.2M Operating Income / Loss $ -356.16M $ -47.14M $ -57.37M Cost of Revenue $ $ $ Net Cash Flow $ -33.32M $ -21.63M $ 14.73M PE Ratio     Splits Jun 02, 2025:   1:20